News and analysis for the global poultry industry.
Industry News & Trends / Business & Markets / Pig Health & Disease / African Swine Fever / Latin America
on May 16, 2019

JBS eager to capitalize on African swine fever situation

Company says its diverse protein portfolio and geographical scope puts it at an advantage

Executives with JBS are optimistic that the Brazil-based multi-protein company will be able to benefit from the African swine fever ASF situation.

Speaking during the company’s first quarter earnings call on May 14, JBS Global CEO Gilberto Tomazoni and Guilherme Cavalcanti, addressed ASF and its potential impact on the company.

To view the full article, please register or login.